Marcus Buggert

Dec 18, 2023 | nature.com | Thomas Muller |Thomas Müller |Marcus Buggert

BackgroundSince its inception, SARS-CoV-2 has continued to impose unprecedented challenges on the medical and scientific communities. The complex and ever-evolving nature of the virus, particularly through the emergence of multiple variants of concern (VOCs) has substantially intensified these challenges. Emerging VOCs not only possess the potential to spread more efficiently but can also possibly evade the human immune response, thus affecting the efficacy of currently available vaccines.

Jul 17, 2023 | nature.com | Marcus Buggert |David Price |Laura K. Mackay

Correction to: Nature Immunology https://doi.org/10.1038/s41590-023-01538-6. Published online 22 June 2023. In the version of this article originally published, there was an error in the table in Fig. 3b: the label currently reading “CCR7” appeared as “CDR7”. The label has been corrected in the HTML and PDF versions of the article.

Jun 22, 2023 | nature.com | Marcus Buggert |David Price |Laura K. Mackay

Authors and AffiliationsCenter for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, SwedenMarcus BuggertDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UKDavid A. PriceSystems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UKDavid A.